Does Dr. ROBIN BRODY have financial conflicts of interest?

Dr. ROBIN BRODY (MD) has received a total of $1,843 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $1,843 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. ROBIN BRODY?

According to CMS Open Payments data, Dr. ROBIN BRODY received funding from GLAXOSMITHKLINE ($591), AERIN MEDICAL ($300), and GENZYME CORPORATION ($272).

Does Dr. ROBIN BRODY receive research grants or speaking fees?

Dr. ROBIN BRODY has received $1,843 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. ROBIN BRODY

MDReal-Time Hydrated

Specialty: Otolaryngology, Otolaryngology/Facial Plastic Surgery

Practice Location: HACKENSACK, NJ 07601

NPI Number: 1841239423

LIFETIME INDUSTRY VALUE

$1,843

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. BRODY is a verified Otolaryngology, Otolaryngology/Facial Plastic Surgery practitioner based in HACKENSACK, NJ.

Between 2021 and 2025, Dr. BRODY had an overall industry promotional and research financial footprint of $1,843 as recorded in the federal CMS Open Payments database.

$1,843 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. BRODY's primary funding source is GLAXOSMITHKLINE, which accounts for $591 (representing 32.1% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

GLAXOSMITHKLINE

Rank 1

$591

32.1%

AERIN MEDICAL

Rank 2

$300

16.3%

GENZYME CORPORATION

Rank 3

$272

14.8%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.